J
eff Galvin, the CEO of American Gene Technologies, has always made investing in his team and the BioHealth Capital Region (BHCR) a top priority.
In the latest sign of the company’s commitment to its employees and the region, AGT recently announced the creation of a Clinical Laboratory Improvement Amendments (CLIA)-certified lab that is actively providing RT-PCR testing for COVID-19.
Image: https://biobuzz-io.cdn.ampproject.org